CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hanshang Group Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hanshang Group Co Ltd
No. 134, Hanyang Avenue
Phone: +86 2768849191p:+86 2768849191 WUHAN, HUB  430050  China Ticker: 600774600774

Business Summary
Hanshang Group Co Ltd is a China-based company mainly engaged in the research, development, production and sales of pharmaceuticals and medical devices, as well as commercial operations and exhibition operations. The Company operates three segments. The Commercial Operations segment is mainly engaged in the commercial operation and management of shopping malls and specialized markets. The Exhibition Operations segment is mainly engaged in the provision of clients with exhibition operation and related services, including the organization, planning, promotion and business development of exhibitions, as well as booth construction, exhibition advertising, plaza event organization, conference services, exhibition equipment rental and parking services. The Pharmaceuticals and Medical Devices segment is mainly engaged in the research, development, production and sales of pharmaceuticals and medical devices in the fields of digestive system, respiratory system and anti-infectives.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202512/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Acting General Manager ZhiYan 52 4/8/2025 1/1/2019
Vice Chairman of the Board ShuweiDu 57 3/20/2020 3/20/2020
Vice Chairman of the Board ZhenyuFeng 52 4/8/2025 1/1/1996
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2,235 (As of 12/31/2024)
Outstanding Shares: 295,032,402 (As of 9/30/2025)
Shareholders: 16,728
Stock Exchange: SHA
Fax Number: +86 2784842384


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026